Utah Medical Products, Inc.
General ticker "UTMD" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $222.0M
Utah Medical Products, Inc. does not follow the US Stock Market performance with the rate: -21.5%.
Estimated limits based on current volatility of 1.2%: low 60.91$, high 62.39$
Factors to consider:
- Company pays dividends: last record date 2024-12-16, amount 0.30$ (Y1.96%)
- Current price 17.1% below estimated low
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [73.78$, 103.53$]
- 2024-12-30 to 2025-12-30 estimated range: [79.60$, 110.92$]
Financial Metrics affecting the UTMD estimates:
- Positive: Non-GAAP EPS, $ of 4.57 > 2.29
- Positive: Operating profit margin, % of 33.40 > 19.51
- Negative: 0 < Industry inventory ratio change (median), % of 0.19
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Inventory ratio change, % of 1.21 > 1.08
- Positive: -0.96 < Investing cash flow per share, $ of -0.18
Short-term UTMD quotes
Long-term UTMD plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $49.05MM | $52.28MM | $50.22MM |
| Operating Expenses | $30.17MM | $32.49MM | $33.45MM |
| Operating Income | $18.88MM | $19.79MM | $16.78MM |
| Non-Operating Income | $0.18MM | $0.87MM | $3.31MM |
| R&D Expense | $0.53MM | $0.49MM | $0.56MM |
| Income(Loss) | $19.06MM | $20.66MM | $20.09MM |
| Taxes | $4.27MM | $4.19MM | $3.45MM |
| Profit(Loss) | $14.79MM | $16.47MM | $16.64MM |
| Stockholders Equity | $107.14MM | $114.25MM | $128.31MM |
| Inventory | $6.60MM | $8.81MM | $9.58MM |
| Assets | $115.64MM | $123.87MM | $135.46MM |
| Operating Cash Flow | $21.20MM | $21.15MM | $22.28MM |
| Capital expenditure | $0.55MM | $0.82MM | $0.64MM |
| Investing Cash Flow | $-0.55MM | $-0.82MM | $-0.64MM |
| Financing Cash Flow | $-10.90MM | $-5.48MM | $-4.17MM |
| Earnings Per Share* | $4.05 | $4.53 | $4.57 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.